Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ESMO Breast Cancer Annual Congress 2023
2023 ASCO Annual Meeting
2023 Society of Surgical Oncology International Conference on Surgical Cancer Care
24th ASBrS Annual Meeting
AACR Annual Meeting 2023
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Advertisement
Advertisement
Jun
04
Today In Oncology
Vorasidenib Delays Disease Progression or Death in Patients With Grade 2 IDH-Mutated Glioma
Radiation May Be Safely Omitted in Select Patients With Locally Advanced Rectal Cancer
Adjuvant Osimertinib Improves Survival in Patients With Resected EGFR-Mutated NSCLC
Nivolumab May Reduce Risk of Disease Progression or Death in Previously Untreated Patients With Hodgkin Lymphoma Compared to Brentuximab Vedotin
Mirvetuximab Soravtansine Improves Survival in Patients With Recurrent Ovarian Cancer
View More
Advertisement
